Outlook Therapeutics (OTLK) EBITDA (2015 - 2026)
Outlook Therapeutics (OTLK) reported EBITDA of -$10.8 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), compared with -$15.72 million a year earlier.
Powered by 
Analysis
Outlook Therapeutics (OTLK) EBITDA (2015 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Outlook Therapeutics' EBITDA came in at -$55.53 million; for FY2025 (ended Sep 30, 2025), it was -$66.94 million.
- By fiscal year, EBITDA came in at -$71.59 million in FY2024, -$53.08 million in FY2023, -$62.87 million in FY2022 and -$51.46 million in FY2021.
- The fiscal Q3 2026 figure ranks as the highest quarterly EBITDA since fiscal Q1 2024.
- Per Business Quant data, the three fiscal quarters before Q3 2026 came in at -$14 million (Q2 2026), -$13.45 million (Q1 2026) and -$17.28 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 9.10 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 8.33 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 999.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 5.09 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 4.63 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -9.70 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 5.89 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.30 Bn |
| 10 | Outlook Therapeutics | 84.78 Mn | 49.03 Mn | -8,265.00 | -10.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -10.80 Mn |
| Mar 31, 2026 | -14.00 Mn |
| Dec 31, 2025 | -13.45 Mn |
| Sep 30, 2025 | -17.28 Mn |
| Jun 30, 2025 | -15.72 Mn |
| Mar 31, 2025 | -12.36 Mn |
| Dec 31, 2024 | -21.58 Mn |
| Sep 30, 2024 | -22.85 Mn |
| Jun 30, 2024 | -19.53 Mn |
| Mar 31, 2024 | -18.91 Mn |
| Dec 31, 2023 | -10.29 Mn |
| Sep 30, 2023 | -12.45 Mn |
| Jun 30, 2023 | -18.13 Mn |
| Mar 31, 2023 | -6.83 Mn |
| Dec 31, 2022 | -15.68 Mn |
| Sep 30, 2022 | -13.94 Mn |
| Jun 30, 2022 | -16.97 Mn |
| Mar 31, 2022 | -18.86 Mn |
| Dec 31, 2021 | -13.10 Mn |
| Sep 30, 2021 | -13.38 Mn |
API Access
Outlook Therapeutics EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=OTLK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "OTLK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=OTLK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();